SPOTLIGHT: Making the case for pharma-doctor friendship


While some critics would vigorously dispute the idea, a representative of the pharma industry is arguing that its close relationships with physicians are actually good for the industry. Pharma outreach to physicians makes sure that the physicians get the latest information on drugs from the companies that know the drugs' strengths and weaknesses best, which helps keep prescribing safe, says Scott Lassman, senior assistant general counsel for the Pharmaceutical Research and Manufacturers of America. Editorial